1. Home
  2. ELA vs KOD Comparison

ELA vs KOD Comparison

Compare ELA & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELA
  • KOD
  • Stock Information
  • Founded
  • ELA 1965
  • KOD 2009
  • Country
  • ELA United States
  • KOD United States
  • Employees
  • ELA N/A
  • KOD N/A
  • Industry
  • ELA Consumer Specialties
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ELA Consumer Discretionary
  • KOD Health Care
  • Exchange
  • ELA Nasdaq
  • KOD Nasdaq
  • Market Cap
  • ELA 138.2M
  • KOD 148.9M
  • IPO Year
  • ELA N/A
  • KOD 2018
  • Fundamental
  • Price
  • ELA $5.20
  • KOD $3.72
  • Analyst Decision
  • ELA
  • KOD Hold
  • Analyst Count
  • ELA 0
  • KOD 5
  • Target Price
  • ELA N/A
  • KOD $3.25
  • AVG Volume (30 Days)
  • ELA 8.6K
  • KOD 191.2K
  • Earning Date
  • ELA 11-06-2024
  • KOD 11-12-2024
  • Dividend Yield
  • ELA N/A
  • KOD N/A
  • EPS Growth
  • ELA N/A
  • KOD N/A
  • EPS
  • ELA 0.24
  • KOD N/A
  • Revenue
  • ELA $155,923,461.00
  • KOD N/A
  • Revenue This Year
  • ELA N/A
  • KOD N/A
  • Revenue Next Year
  • ELA $10.07
  • KOD N/A
  • P/E Ratio
  • ELA $21.55
  • KOD N/A
  • Revenue Growth
  • ELA N/A
  • KOD N/A
  • 52 Week Low
  • ELA $3.02
  • KOD $1.37
  • 52 Week High
  • ELA $5.80
  • KOD $7.77
  • Technical
  • Relative Strength Index (RSI)
  • ELA 42.62
  • KOD 83.00
  • Support Level
  • ELA $5.28
  • KOD $2.54
  • Resistance Level
  • ELA $5.40
  • KOD $3.75
  • Average True Range (ATR)
  • ELA 0.13
  • KOD 0.18
  • MACD
  • ELA -0.03
  • KOD 0.11
  • Stochastic Oscillator
  • ELA 22.58
  • KOD 95.12

About ELA Envela Corporation

Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Share on Social Networks: